Atrial fibrillation is the most common cardiac arrhythmia and is associated with an increased risk of embolic events. Routine screening facilitates timely detection and treatment. Oral anticoagulants are recommended as therapy in most cases, and the risk of bleeding and stroke can be assessed by specific scores. The NOAK/DOAK substance class is nowadays considered more important than vitamin K antagonists.